Advertisement

Topics

Latest Biotechnology, Pharmaceutical and Healthcare News from Pharmaceutical Technology

22:05 EST 17th January 2019 | BioPortfolio

Here are the most relevant search results for "Pharmaceutical Technology" found in our extensive news archives from over 250 global news sources.

More Information about Pharmaceutical Technology on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Pharmaceutical Technology for you to read. Along with our medical data and news we also list Pharmaceutical Technology Clinical Trials, which are updated daily. BioPortfolio also has a large database of Pharmaceutical Technology Companies for you to search.

Showing News Articles 1–25 of 1,300+ from Pharmaceutical Technology

Thursday 17th January 2019

RPA adoption strong among US medium-sized businesses, survey says

Robotic process automation (RPA) continues to see robust adoption among medium-sized businesses in the US, according to a survey by...Read More... The post RPA adoption strong among US medium-sized businesses, survey says appeared first on Pharmaceutical Technology.

Bremelanotide expected to find adherents, say experts

A recently produced US drug designed to help women with hypoactive sexual desire disorder (HSDD) is likely to enjoy better...Read More... The post Bremelanotide expected to find adherents, say experts appeared first on Pharmaceutical Technology.

Report finds NICE unaware of financial interests of patient groups

A report by the London School of Tropical Medicine (LSTM) found that patient organisations consulted by the UK’s National institute...Read More... The post Report finds NICE unaware of financial interests of patient groups appeared first on Pharmaceutical Technology.

Wednesday 16th January 2019

Teva secures US regulatory approval for generic version of Sabril

Teva Pharmaceuticals USA has secured approval from the US Food and Drug Administration (FDA) for its generic version of Sabril...Read More... The post Teva secures US regulatory approval for generic version of Sabril appeared first on Pharmaceutical Technology.

European and UK pharma industry call for action as parliament rejects Brexit deal

The European and UK pharma industry have called for preparations to ensure that patients will have access to their medications...Read More... The post European and UK pharma industry call for action as parliament rejects Brexit deal appeared first on Pharmaceutical Technology.

AstraZeneca licences Luye Pharma cholesterol drug in China

Luye Pharma has granted AstraZeneca’s Chinese division exclusive rights to promote its cholesterol medicine Xuezhikang Capsules in mainland China. The...Read More... The post AstraZeneca licences Luye Pharma cholesterol drug in China appeared first on Pharmaceutical Technology.

FDA announces new policies for cell and gene therapies

Despite most of the US Food and Drug Administration’s (FDA) responsibilities grinding to a halt as a result of the...Read More... The post FDA announces new policies for cell and gene therapies appeared first on Pharmaceutical Technology.

IBM & MineHub blockchain platform to track minerals in supply chain

IT giant IBM and tech firm MineHub Technologies have partnered to use blockchain technology to track high-value minerals across the...Read More... The post IBM & MineHub blockchain platform to track minerals in supply chain appeared first on Pharmaceutical Technology.

Will robotics save the day for Big Pharma?

With drug pricing and reimbursement cited as a major obstacle for the pharmaceutical industry in a recent survey, the question...Read More... The post Will robotics save the day for Big Pharma? appeared first on Pharmaceutical Technology.

Tuesday 15th January 2019

US Oversight Committee launches drug price probe into major companies

The US Committee on Oversight and Reform chairman Elijah Cummings has launched an investigation into the drug pricing practices of...Read More... The post US Oversight Committee launches drug price probe into major companies appeared first on Pharmaceutical Technology.

US Oversight Committee launches drug price probe against major companies

The US Committee on Oversight and Reform chairman Elijah Cummings has launched an investigation into the drug pricing practices of...Read More... The post US Oversight Committee launches drug price probe against major companies appeared first on Pharmaceutical Technology.

Eisai and Purdue Pharma seek US approval for lemborexant to treat insomnia

Eisai and its partner Purdue Pharma have submitted new drug application to the US Food and Drug Administration (FDA) seeking...Read More... The post Eisai and Purdue Pharma seek US approval for lemborexant to treat insomnia appeared first on Pharmaceutical Technology.

Sanofi and Biomunex partner to develop antibody therapeutics

Sanofi has signed a licensing agreement with French biopharmaceutical firm Biomunex Pharmaceuticals for the development of antibody-based drugs. As part...Read More... The post Sanofi and Biomunex partner to develop antibody therapeutics appeared first on Pharmaceutical Technology.

Despite promise, ongoing Phase III uncertain for Catalyst’s Firdapse in MuSK-MG

Despite positive data observed with Catalyst Pharmaceuticals’ Firdapse (amifampridine phosphate) in a proof-of-concept (POC) investigator-sponsored trial in muscle-specific tyrosine kinase myasthenia gravis...Read More... The post Despite promise, ongoing Phase III uncertain for Catalyst’s Firdapse in MuSK-MG appeared first on Pharmaceutical Technology.

US government shutdown: should the FDA go independent?

As the partial US government shutdown continues into its third week, the FDA has been operating at reduced capacity, curbing...Read More... The post US government shutdown: should the FDA go independent? appeared first on Pharmaceutical Technology.

Blue Water stakes claim on universal flu vaccine with Oxford Uni deal

Blue Water Vaccines announced news of a potential agreement with the University of Oxford, allowing the company to exclusively license...Read More... The post Blue Water stakes claim on universal flu vaccine with Oxford Uni deal appeared first on Pharmaceutical Technology.

BMS/Celgene deal will create haematology powerhouse

Although Bristol-Myers Squibb (BMS) was already a leader in oncology, its proposed $74 billion acquisition of Celgene will further position...Read More... The post BMS/Celgene deal will create haematology powerhouse appeared first on Pharmaceutical Technology.

Monday 14th January 2019

Ascletis Pharma to develop Alphamab’s viral diseases drug in China

Ascletis Pharma has signed an exclusive licensing agreement with Suzhou Alphamab to develop an investigational candidate, KN035, for the treatment...Read More... The post Ascletis Pharma to develop Alphamab’s viral diseases drug in China appeared first on Pharmaceutical Technology.

FDA agrees to review Pfizer’s NDAs for tafamidis

The US Food and Drug Administration (FDA) has accepted Pfizer’s two new drug applications (NDAs) for tafamidis to treat transthyretin...Read More... The post FDA agrees to review Pfizer’s NDAs for tafamidis appeared first on Pharmaceutical Technology.

Sunday 13th January 2019

Knight Therapeutics licences cancer drug from Puma Biotechnology

Canada-based Knight Therapeutics signed an exclusive licence agreement with Puma Biotechnology to commercialise Nerlynx (neratinib) medicine in the country. Nerlynx...Read More... The post Knight Therapeutics licences cancer drug from Puma Biotechnology appeared first on Pharmaceutical Technology.

UK and Japan partner on treatments for degenerative diseases

Medical researchers in the UK and Japan are set to work together on advancing research aimed at developing treatments for...Read More... The post UK and Japan partner on treatments for degenerative diseases appeared first on Pharmaceutical Technology.

Global Fund seeks $14bn to fight AIDS, TB and malaria

An international health fund that finances the fight against acquired immune deficiency syndrome (AIDS), tuberculosis (TB) and malaria has announced...Read More... The post Global Fund seeks $14bn to fight AIDS, TB and malaria appeared first on Pharmaceutical Technology.

Friday 11th January 2019

Could the Ethereum Classic attack happen to other blockchain networks?

Late on Saturday evening, major cryptocurrency exchange Coinbase detected an attack on the Etheruem Classic blockchain. Coinbase’s subsequent investigation showed...Read More... The post Could the Ethereum Classic attack happen to other blockchain networks? appeared first on Pharmaceutical Technology.

Evolus’s ‘frown line’ treatment Jeuveau could threaten Botox revenues

Evolus’ Jeuveau (DWP-450) (prabotulinumtoxinA) will likely prove to be a strong competitor to Allergan’s Botox (botulinum toxin type A) for severe glabellar (frown) lines,...Read More... The post Evolus’s ‘frown line’ treatment Jeuveau could threaten Botox revenues appeared first on Pharmaceutical Technology.

Second Chance for opioid users, a smartphone app to detect overdose

A smartphone app called Second Chance has been developed to detect overdose-related symptoms in opioid users by using sonar to...Read More... The post Second Chance for opioid users, a smartphone app to detect overdose appeared first on Pharmaceutical Technology.


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks